Navigation Links
Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting

eliver ARIAD's lead cancer product candidate to prevent reblockage at sites of vascular injury following stent-assisted angioplasty. ARIAD has an exclusive license to pioneering technology and patents related to certain NF-(kappa)B treatment methods, and the discovery and development of drugs to regulate NF-(kappa)B cell-signaling activity, which may be useful in treating certain diseases. Additional information about ARIAD can be found on the web at http://www.ariad.com.

This press release contains "forward-looking statements," including statements related to initiation of our Phase 3 clinical trial in metastatic sarcomas in the third quarter of 2007. Forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the costs associated with our research, development, manufacturing and other activities, the conduct and results of pre-clinical and clinical studies of our product candidates, difficulties or delays in obtaining regulatory approvals to market products resulting from our development efforts, our reliance on partners and other key parties for the successful development, manufacturing and commercialization of products, the adequacy of our capital resources and the availability of additional funding, patent protection and third-party intellectual property claims relating to our and any partner's product candidates, the timing, scope, cost and outcome of legal and patent office proceedings concerning our NF-(kappa)B patent portfolio, the potential acquisition of or other strategic transaction regarding the minority stockholders' interests in our 80%-owned subsidiary, ARIAD Gene Therapeutics, Inc., future capital needs, key employees, markets, economic conditions, prices, reimbursement r
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:7/3/2015)... , July 4, 2015 ... les épidémies que sont l,hypertension, le diabète et ... Sud-Est, par l,intermédiaire de plateformes éducatives gratuites et ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) , ... le diabète en ligne , Prendre en ...
(Date:7/3/2015)... July 3, 2015 According ... & Cardiac Rhythm Management Market ECG, Implantable Loop ... Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P ... the global Cardiac Monitoring (CM) and Cardiac Rhythm ... $26,646.5 Million by 2020 from $21,137.7 Million in ...
(Date:7/3/2015)... 3, 2015 A global continuing ... diabetes and thyroid disorders in Latin America ... major conference dedicated to these diseases.      ... , Manage Hypertension Online and Manage ... EXCEMED - combine the world,s top expertise ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2
... June 3, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... chairman and chief executive officer, is scheduled to present a ... New York City on Wednesday, June 8th at 2:30 pm ... can be accessed at www.rigel.com .  Please connect to ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... Abbreviated New Drug Application (ANDA) with the U.S. Food ... Citrate Tablets, 25, 50 and 100 mg. Watson,s Sildenafil ... Viagra®, which is indicated for the treatment of erectile ...
Cached Medicine Technology:Watson Confirms Viagra® Patent Challenge 2
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, ... Lake Orion. These classes are geared towards families that want their children to ... , The fitness class will take place TUESDAYS at 4:30pm. Questions? Call ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a ... of 2 months of unlimited classes for just $65. Student ID is needed at ... Lapeer Road in Lake Orion. , Women’s Excellence is the most ...
(Date:7/4/2015)... ... ... Dating a real millionaire online can be more difficult. Millionairematchapp.com is ... remove the worries from meeting partners. Recently, the site announced they're publishing of ... readers have responded with excitement. , “There's quite a few millionaire dating apps ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain ... have pain located in the neck. Another 19% suffer from head, migraine, or facial ... suggests that 45% of American workers must deal with neck pain. Strategies ...
Breaking Medicine News(10 mins):Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3
... be an effective therapy to treat and even prevent allergy ... patients with cystic fibrosis and asthma, according to researchers from ... School of Medicine and Louisiana State University School of Medicine., ... a lung disease researcher at Children,s Hospital and professor of ...
... novel mechanism used by adenovirus to sidestep the cell,s suicide ... suppressor genes are silenced in tumor cells and pave the ... researchers at the Salk Institute for Biological Studies in the ... a cell is under stress, the tumor suppressor p53 springs ...
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) ... by a U.S. judge to halt any expansion of ... injunction, which basically blindsided the scientific community, effectively takes ... That was when then-President George W. Bush ordered that ...
... , TUESDAY, Aug. 24 (HealthDay News) -- Adding therapy ... attention-deficit/hyperactivity disorder (ADHD) could lessen symptoms and improve quality ... year, patients receiving cognitive behavioral therapy along with their ... relaxation exercises. "We have known that therapy helps, ...
... surge of scientific research has uncovered telltale signs of ... spinal taps, many questions remain unanswered about the clinical ... patient care, according to Dr. Kenneth S. Kosik, Harriman ... and co-director of UCSB,s Neuroscience Research Institute. Kosik, ...
... Reinberg HealthDay Reporter , TUESDAY, Aug. 24 ... health benefits of drinking continues to bubble, a new ... higher mortality risk than moderate drinkers. "This ... association between moderate alcohol intake and health benefits with ...
Cached Medicine News:Health News:Vitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patients 2Health News:Use the common cold virus to target and disrupt cancer cells? 2Health News:Use the common cold virus to target and disrupt cancer cells? 3Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3Health News:Cognitive Therapy Helps Adults With ADHD 2Health News:Are early testing and drug development the most pressing issues in Alzheimer's care? 2Health News:A Little Drinking Cuts Death Risk for Older Adults 2Health News:A Little Drinking Cuts Death Risk for Older Adults 3Health News:A Little Drinking Cuts Death Risk for Older Adults 4
... is how one neurosurgeon describes samples taken ... "beautiful he means a,cleaner cut and larger ... the needles optimized vacuum and cutting edge., ... thumb nut holds vacuum,in the needle so ...
CVC 9005 Hematocrit Calibration Verification Controls are materials used for verifying the calibration and linearity of hematocrit sensors in IRMA TRUpoint cartridges for systems using software versi...
... is an assayed quality control ... measurements of total hemoglobin and ... It is available in three ... performance at varying points within ...
... is an assayed quality control material used for ... CO-Oximeter instrumentation. It is for specific use on ... fractions (280, 288, and 270) and the AVOX ... also be used on the IRMA TRUpoint. CC ...
Medicine Products: